Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Elephantiasis, Filarial

3,4-methylenedioxyamphetamine has been researched along with Elephantiasis, Filarial in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Elephantiasis, Filarial: Parasitic infestation of the human lymphatic system by WUCHERERIA BANCROFTI or BRUGIA MALAYI. It is also called lymphatic filariasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fuller, BB1
Harris, V1
Parker, C1
Martinez, A1
Toubali, E1
Ebene, BC1
Asemanyi-Mensah, K1
Dembele, M1
Salissou, AB1
Kabré, C1
Meite, A1
Kane, NM1
Kargbo-Labour, I1
Batcho, W1
Diaby, A1
Yevstigneyeva, V1
Stukel, DM1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Elephantiasis, Filarial

ArticleYear
Contextual determinants of mass drug administration performance: Modelling fourteen years of lymphatic filariasis treatments in West Africa.
    PLoS neglected tropical diseases, 2023, Volume: 17, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Africa, Western; COVID-19; Elephantiasis, Filarial; Filaricides; Hemo

2023